MTX are set to build Royal Surrey County Hospital’s state-of-the-art Cancer and Surgical Innovation Centre and prove once again the value of offsite methods to the healthcare sector.
Modern methods of construction (MMC) specialist MTX has been awarded the contract to deliver Royal Surrey County Hospital’s Cancer and Surgical Innovation Centre, which will offer state-of-the-art facilities and include six new operating theatres.
The £41.5million two-storey development will build on Royal Surrey County Hospital’s world-class services in robotic and non-robotic surgery and enable an additional 7,000 patients to receive surgery every year. The investment in new facilities will help Royal Surrey respond to increasing demand for cancer surgery and bring down waiting lists for all elective surgical procedures.
MTX employs MMC and Design for Manufacture and Assembly (DfMA) principles to deliver new facilities faster, safer, greener and more cost effectively than conventional building methods.
Their fast-track processes enable groundworks to take place on-site while precisely engineered structural steel units are factory manufactured offsite for delivery and installation. The result is a reduction in programme duration and earlier delivery of new facilities that are purpose-designed and fully compliant, to more quickly benefit patients.
MTX Pre-Construction Director Mike Butler explained: “MTX has a proven track record in supporting NHS Trusts in the delivery of vitally needed new facilities and we are delighted to be partnering with Royal Surrey to create this exciting new Cancer and Surgical Centre. Our expertise and resources support our Trust partners at every step of the journey, from concept design, through to completion and handover. This ensures each facility is fully compliant and a resource that will deliver a rapid return on investment for the Trust, as well as enhanced services for patients.”
Royal Surry NHS Foundation Trust Deputy Chief Executive Ross Dunworth said: “We are pleased to have awarded the contract for this major development to MTX, who have extensive experience of similar construction at other NHS trusts. The new Cancer and Surgical Innovation Centre will be a huge step forward for Royal Surrey and transform the care we are able to provide to our patients. Many members of staff, patients, visitors and our charitable supporters are closely following the progress with ground works on-site and updates on the units being built offsite. There is a shared sense of excitement around this £40million plus development and we are very much looking forward to opening and using the new centre.”
The new centre will link to the main hospital and its existing operating theatres. It will serve as the main entrance for surgical patients attending the hospital with the exception of paediatric and day surgery patients, which will remain as a separate unit in its current location. The new facility will replace Royal Surrey’s ageing Surgical Short Stay Unit.
Royal Surrey is one of the largest cancer centres in the country. A total of 60% of all surgeries performed at Royal Surrey are cancer-related, and the Trust supports a large catchment area across the South East of England and beyond of up to three million people – just under 5% of the UK’s population.
For more information visit: www.mtx.co.uk
